In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC label reform proposal comment period extended until Oct. 6.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL REFORM PROPOSAL COMMENT DEADLINE TO BE EXTENDED by FDA for 100 days, from June 27 to Oct. 6. The extension responds to re-quests for more time from the Nonprescription Drug Manufacturers Association and the Cosmetic, Toiletry & Fragrance Association. NDMA had requested a 90-day extension and CTFA asked for an additional 120 days. FDA informed the associations about the extension in May 22 letters.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts